Nasdaq

OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s First FDA Authorization for a Whole Exome Sequencing Platform

BETHLEHEM, Pa., Jan. 21, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and ...
Seeking Alpha

OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)

FDA Clearance Received Through Partnership with Grifols to Support Screening for Risk of Alpha 1 - Antripsyn Deficiency (Alpha-1) in U.S. Adult Population BETHLEHEM, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE ...